Hester Biosciences exploring various opportunities to increase product portfolio

29 Oct 2018 Evaluate

Hester Biosciences is exploring various opportunities to increase the product portfolio and turnover. The company has reported net sales of Rs 80.80 crore in H1FY19 as compared to Rs 67.52 crore for the corresponding period of previous year, registering a growth of around 20%.

Hester Biosciences is engaged in the manufacturing of poultry vaccines.

Hester Biosciences Share Price

1649.00 17.95 (1.10%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×